OnCusp Therapeutics is a startup based in the United States, most recent round Series A, 1 tracked investor.
Based in the United States, OnCusp Therapeutics is a startup founded in 2021. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
OnCusp Therapeutics is a biotechnology company developing a portfolio of therapeutic assets for cancer patients, advancing oncology drug candidates toward clinical development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.